<DOC>
	<DOCNO>NCT00001131</DOCNO>
	<brief_summary>The purpose study find immune system HIV-positive patient improve treatment anti-HIV medication plus interleukin-2 ( IL-2 ) early stage HIV infection . IL-2 protein find naturally blood help boost immune system . HIV spread throughout body invade CD4 cell , cell immune system fight infection . Doctors hope add IL-2 current anti-HIV drug combination help restore CD4 cell count immune function . This study look HIV virus act early stage HIV infection , immune system respond HIV , impact early treatment anti-HIV medication course HIV infection .</brief_summary>
	<brief_title>Effectiveness Interleukin-2 ( IL-2 ) Plus Anti-HIV Therapy HIV-Positive Patients</brief_title>
	<detailed_description>At time initial HIV infection , CD4 cell susceptible infection , virus infects many T cell first 4 6 week . Many infected cell subsequently maintain virus latent state . Immune reconstitution daily low-dose IL-2 therapy intend correct improve deficiency CD4 cell , maintain high frequency CD8+ HIV-specific CTL increase natural killer ( NK ) cell . After year HAART plus IL-2 , may possible discontinue HAART maintain IL-2 stimulatory therapy , immune reactivity repair stimulate IL-2 able contain virus maintain latency . Patients randomized add IL-2 current HAART regimen simply remain current HAART regimen . IL-2 therapy initiate Month 3 HAART . IL-2 inject subcutaneously daily 9 month , addition HAART . After completion 1-year treatment period , patient evaluate discontinuation HAART . Patients viral load 50 copies/ml throughout HAART plus IL-2 , CD4 count least 500 cells/mm3 , onset opportunistic infection may HAART discontinue IL-2 continue monotherapy additional 6 month . After complete 6 month IL-2 monotherapy , eligible patient may IL-2 therapy discontinue .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Aldesleukin</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : HIVinfected . Viral load 5,000 copies/ml less within 3 month . Completed least 3 month antiHIV medication . Have refrigerator store needle IL2 shot . Exclusion Criteria Glucocorticoids drug affect immune system INFalpha , GCSF , GMCSF .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Interleukin-2</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Drug Administration Schedule</keyword>
	<keyword>Viremia</keyword>
	<keyword>T-Lymphocytes , Cytotoxic</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>